Equasens Société anonyme (0R9T.L)

EUR 40.2

(5.51%)

Eps Summary of Equasens Société anonyme

Equasens Société anonyme's latest annual eps in 2023 was 3.13 EUR , up 1.62% from previous year.
Equasens Société anonyme's latest quarterly eps in 2024 Q2 was 0.57 EUR , down 0.0% from previous quarter.
Equasens Société anonyme reported an annual eps of 3.08 EUR in 2022, up 18.46% from previous year.
Equasens Société anonyme reported an annual eps of 2.60 EUR in 2021, up 27.45% from previous year.
Equasens Société anonyme reported a quarterly eps of 0.57 EUR for 2024 Q2, down 0.0% from previous quarter.
Equasens Société anonyme reported a quarterly eps of N/A for 2023 FY, up 1.62% from previous quarter.

Annual Eps Chart of Equasens Société anonyme (2023 - 2004)

Historical Annual Eps of Equasens Société anonyme (2023 - 2004)

Year	Eps	Eps Growth
2023	3.13 EUR	1.62%
2022	3.08 EUR	18.46%
2021	2.60 EUR	27.45%
2020	2.04 EUR	7.94%
2019	1.89 EUR	11.18%
2018	1.70 EUR	9.68%
2017	1.55 EUR	13.14%
2016	1.37 EUR	9.6%
2015	1.25 EUR	9.65%
2014	1.14 EUR	9.62%
2013	1.04 EUR	16.85%
2012	0.89 EUR	14.1%
2011	0.78 EUR	6.85%
2010	0.73 EUR	14.06%
2009	0.64 EUR	6.67%
2008	0.60 EUR	205.26%
2007	-0.57 EUR	-216.33%
2006	0.49 EUR	28.95%
2005	0.38 EUR	15.15%
2004	0.33 EUR	0.0%

Year	Eps	Eps Growth
2024 Q1	0.57 EUR	-30.49%
2024 Q2	0.57 EUR	0.0%
2023 FY	- EUR	1.62%
2023 Q2	1.46 EUR	100.0%
2023 Q3	0.82 EUR	-43.84%
2023 Q4	0.82 EUR	0.0%
2023 Q1	0.73 EUR	-58.52%
2022 Q4	1.76 EUR	0.0%
2022 Q1	0.65 EUR	-56.67%
2022 FY	- EUR	18.46%
2022 Q2	1.31 EUR	101.54%
2021 Q2	1.10 EUR	103.7%
2021 FY	- EUR	27.45%
2021 Q3	0.75 EUR	-31.82%
2021 Q1	0.54 EUR	-55.0%
2021 Q4	1.50 EUR	100.0%
2020 Q1	0.42 EUR	-57.14%
2020 Q2	0.84 EUR	100.0%
2020 FY	- EUR	7.94%
2020 Q3	0.60 EUR	-28.57%
2020 Q4	1.20 EUR	100.0%
2019 Q2	0.91 EUR	127.5%
2019 Q4	0.98 EUR	100.0%
2019 Q1	0.40 EUR	-56.99%
2019 FY	- EUR	11.18%
2019 Q3	0.49 EUR	-46.15%
2018 Q2	0.75 EUR	97.37%
2018 FY	- EUR	9.68%
2018 Q4	0.93 EUR	102.17%
2018 Q3	0.46 EUR	-38.67%
2018 Q1	0.38 EUR	-55.81%
2017 Q1	0.34 EUR	-51.43%
2017 Q3	0.43 EUR	-35.82%
2017 Q4	0.86 EUR	100.0%
2017 Q2	0.67 EUR	97.06%
2017 FY	- EUR	13.14%
2016 Q4	0.70 EUR	100.0%
2016 FY	- EUR	9.6%
2016 Q2	0.66 EUR	100.0%
2016 Q3	0.35 EUR	-46.97%
2016 Q1	0.33 EUR	-47.62%
2015 Q1	0.30 EUR	-45.45%
2015 Q3	0.32 EUR	-47.54%
2015 Q2	0.61 EUR	103.33%
2015 FY	- EUR	9.65%
2015 Q4	0.63 EUR	96.88%
2014 Q4	0.55 EUR	103.7%
2014 Q1	0.29 EUR	-43.14%
2014 FY	- EUR	9.62%
2014 Q2	0.57 EUR	96.55%
2014 Q3	0.27 EUR	-52.63%
2013 Q3	0.26 EUR	-50.94%
2013 Q1	0.27 EUR	0.0%
2013 FY	- EUR	16.85%
2013 Q2	0.53 EUR	96.3%
2013 Q4	0.51 EUR	96.15%
2012 FY	- EUR	14.1%
2011 FY	- EUR	6.85%
2010 FY	- EUR	14.06%
2009 FY	- EUR	6.67%
2008 FY	- EUR	205.26%
2007 FY	- EUR	-216.33%
2006 FY	- EUR	28.95%
2005 FY	- EUR	15.15%
2004 FY	- EUR	0.0%

Peer Eps Comparison of Equasens Société anonyme

Name	Eps	Eps Difference
Cegedim SA	-0.54 EUR	679.63%
Guerbet SA	1.90 EUR	-64.737%
Nexus AG	1.39 EUR	-125.18%
Bastide Le Confort Médical SA	-0.12 EUR	2708.333%
Revenio Group Oyj	0.72 EUR	-334.722%
Drägerwerk AG & Co. KGaA	5.89 EUR	46.859%
Sartorius Aktiengesellschaft	3.00 EUR	-4.333%
LNA Santé SA	2.29 EUR	-36.681%
Siemens Healthineers AG	1.74 EUR	-79.885%
Medios AG	0.79 EUR	-296.203%
Stratec SE	1.07 EUR	-192.523%